Open-angle Glaucoma
📧 Sign up to get email alerts when something new happens for Open-angle Glaucoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-11-10Clinical Trial Update: Does the Optic Disc Grading Done Visually by Your Doctor Agree With Optic Nerve Testing Which is Done by Machines?
A completed clinical trial evaluated whether doctors' visual grading of the optic disc agrees with machine-based optic nerve testing in Open…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma [Phase 2]
Phase 2 study of RO5093151 in ocular hypertension and open-angle glaucoma has been completed.
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Study of CyPass Implantation In Patients With Open Angle Glaucoma Refractory to Single or Multi-agent Topical Therapy [NA]
A completed clinical trial study evaluated CyPass Micro-Stent implantation in patients with primary open-angle glaucoma refractory to topica…
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Effect of Cosopt Versus Combigan on Retinal Vascular Autoregulation in Primary Open Angle Glaucoma (POAG) [NA]
A completed clinical trial compared Cosopt with Combigan for retinal vascular autoregulation in primary open-angle glaucoma. Results were po…
-
CLINICAL_TRIALS trial_result · 2016-10-20Clinical Trial Update: Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery [NA]
This clinical trial update reports completion and posted results for an implantable device designed to lower intraocular pressure in patient…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: Evaluation of Pascal Laser Trabeculoplaty [NA]
Clinical trial evaluating Pascal Laser Trabeculoplasty for open-angle glaucoma and ocular hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: Comparing Acular LS and Pred Forte in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells [NA]
A terminated clinical trial comparing Acular LS (ketorolac tromethamine) and Pred Forte (prednisolone acetate) for reducing post-laser trabe…
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Safety and Efficacy of Three Variants of Canaloplasty With Phacoemulsification to Treat Glaucoma and Cataract [NA]
This clinical trial update reports on the safety and efficacy of three canaloplasty variants with phacoemulsification for the treatment of p…
-
CLINICAL_TRIALS trial_result · 2016-08-16Clinical Trial Update: Different Glaucoma Treatments Effect on Intraocular Pressure Fluctuation With Postural Change in Eyes With Open-angle Glaucoma
This study evaluates how different glaucoma treatments affect intraocular pressure fluctuations with changes in posture in open-angle glauco…
-
FDA approval · 2016-08-09FDA Approved: TIMOPTIC — Supplemental Application (Bausch & Lomb Incorporated)
FDA approved a supplemental application for Timoptic (timolol maleate) from Bausch & Lomb, authorizing updates to the product via an NDA sup…
-
CLINICAL_TRIALS trial_result · 2016-08-09Clinical Trial Update: Trial Comparing Ketorolac Tromethamine 0.4% & Prednisolone Acetate 1% in Reducing Post-SLT Anterior Chamber Flare & Cells
A clinical trial comparing ketorolac tromethamine 0.4% to prednisolone acetate 1% for reducing postoperative anterior chamber inflammation a…
-
CLINICAL_TRIALS trial_result · 2016-08-08Clinical Trial Update: Efficacy of Travoprost/Timolol for Uncontrolled Intraocular Pressure [Phase 4]
Alcon completed a Phase 4 trial evaluating Travoprost/Timolol for uncontrolled intraocular pressure in open-angle glaucoma and ocular hypert…
-
FDA approval · 2016-08-05FDA Approved: BETAXOLOL HYDROCHLORIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for betaxolol hydrochloride by Sandoz Inc, updating its labeling/approval for use in open-angle glau…
-
CLINICAL_TRIALS trial_result · 2016-08-02Clinical Trial Update: NT-501 CNTF Implant for Glaucoma: Safety, Neuroprotection and Neuroenhancement [Phase 1]
Phase 1 study evaluating the NT-501 CNTF implant for safety, neuroprotection, and neuroenhancement in glaucoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-02Clinical Trial Update: Diurnal and Nocturnal Effect of Travatan With SofZia Preservative on Intraocular Pressure and Ocular Perfusion Pressure
Clinical trial evaluating diurnal and nocturnal effects of Travatan Z with SofZia preservative on intraocular pressure and ocular perfusion …
-
CLINICAL_TRIALS trial_result · 2016-07-28Clinical Trial Update: Effect of Travoprost 0.004% on Retinal Oximetry in Primary Open Angle Glaucoma [NA]
A completed clinical trial evaluated the effect of Travoprost 0.004% on retinal oximetry in primary open-angle glaucoma, with results posted…
-
CLINICAL_TRIALS trial_result · 2016-05-30Clinical Trial Update: Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial update for SPARC0912 and Reference0912 in open angle glaucoma and ocular hypertension; results posted in 2016.
-
FDA approval · 2016-05-05FDA Approved: ALPHAGAN P — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for ALPHAGAN P (brimonidine tartrate), approving changes to the product labeling requested by Allerg…
-
CLINICAL_TRIALS trial_result · 2016-05-05Clinical Trial Update: Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial evaluating safety of SPARC0913 in open angle glaucoma and ocular hypertension has completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: 28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension [Phase 1]
Phase 1 study evaluating safety and activity of 5 escalating doses of SAR366234 plus a single dose of latanoprost in open-angle glaucoma or …
-
FDA approval · 2016-04-22FDA Approved: LATANOPROST — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved a generic latanoprost product from Rising Pharma Holdings, Inc. via an Original Application (ANDA 202442) to reduce intraoc…
-
CLINICAL_TRIALS trial_result · 2016-04-22Clinical Trial Update: Associations of Vitamin D Deficiency and Vitamin D Receptor Polymorphisms With the Risk of Primary Open-angle Glaucoma
This clinical trial update reports on associations between vitamin D deficiency and vitamin D receptor polymorphisms with the risk of primar…
-
FDA approval · 2016-04-19FDA Approved: BIMATOPROST — Original Application (Sandoz Inc)
FDA approved the original ANDA for bimatoprost ophthalmic solution by Sandoz, establishing a generic version of this glaucoma medication.
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort
This post-approval study provides extended follow-up data on the iStent trabecular micro-bypass stent in patients with primary open-angle gl…
-
CLINICAL_TRIALS trial_result · 2016-04-01Clinical Trial Update: Safety of Hyaluronan Thiomer i.o. Implant During Combined Phacoemulsification - Non Penetrating Deep Sclerectomy [Phase 1]
A Phase 1 study evaluated the safety of the Hyaluronan Thiomer intraocular implant used during combined phacoemulsification cataract surgery…